Syngene International Ltd received an Establishment Inspection Report (EIR) from the USFDA on June 11, 2025, indicating a Voluntary Action Indicated (VAI) outcome from their inspection conducted from February 10 to February 20, 2025, and they will continue to address the findings without impact on financials or operations.